{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:33:40Z","timestamp":1791405220487,"version":"4.3.3"},"reference-count":145,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI12\/02529"],"award-info":[{"award-number":["PI12\/02529"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI15\/01206"],"award-info":[{"award-number":["PI15\/01206"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP15\/00103"],"award-info":[{"award-number":["CP15\/00103"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD12\/0013\/0001"],"award-info":[{"award-number":["RD12\/0013\/0001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16\/0006\/0001"],"award-info":[{"award-number":["RD16\/0006\/0001"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP15\/00103"],"award-info":[{"award-number":["CP15\/00103"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CM16\/00057"],"award-info":[{"award-number":["CM16\/00057"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["JR15\/00036"],"award-info":[{"award-number":["JR15\/00036"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002878","name":"Consejer\u00eda de Econom\u00eda, Innovaci\u00f3n, Ciencia y Empleo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["CTS-06603"],"award-info":[{"award-number":["CTS-06603"]}],"id":[{"id":"10.13039\/501100002878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["RYC-2013-13138"],"award-info":[{"award-number":["RYC-2013-13138"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2017.00614","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T03:44:19Z","timestamp":1496029459000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":124,"title":["Epidemiology, Mechanisms, and Diagnosis of Drug-Induced Anaphylaxis"],"prefix":"10.3389","volume":"8","author":[{"given":"Maria Isabel","family":"Monta\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristobalina","family":"Mayorga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gador","family":"Bogas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Barrionuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Fernandez-Santamaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Martin-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Julio","family":"Laguna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jos\u00e9","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahia Diana","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inmaculada","family":"Do\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"S402","DOI":"10.1016\/j.jaci.2007.08.061","article-title":"9. Anaphylaxis","volume":"121","author":"Simons","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: report of the nomenclature review committee of the World Allergy Organization, October 2003","volume":"113","author":"Johansson","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report \u2013 second national institute of allergy and infectious disease\/food allergy and anaphylaxis network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jaci.2008.10.049","article-title":"Anaphylaxis fatalities and admissions in Australia","volume":"123","author":"Liew","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.jaci.2010.02.009","article-title":"Anaphylaxis epidemiology in patients with and patients without asthma: a United Kingdom database review","volume":"125","author":"Gonzalez-Perez","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.jaci.2013.08.016","article-title":"Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States","volume":"133","author":"Wood","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jaci.2011.09.018","article-title":"Anaphylaxis in a New York City pediatric emergency department: triggers, treatments, and outcomes","volume":"129","author":"Huang","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B8","first-page":"262","article-title":"Anaphylaxis: a ten years inpatient retrospective study","volume":"28","author":"Techapornroong","year":"2010","journal-title":"Asian Pac J Allergy Immunol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1111\/all.12012","article-title":"Anaphylaxis in an emergency setting \u2013 elicitors, therapy and incidence of severe allergic reactions","volume":"67","author":"Beyer","year":"2012","journal-title":"Allergy"},{"key":"B10","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.jaip.2014.03.014","article-title":"Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis","volume":"2","author":"Aun","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1016\/j.jaci.2014.08.018","article-title":"Fatal anaphylaxis in the United States, 1999\u20132010: temporal patterns and demographic associations","volume":"134","author":"Jerschow","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jaip.2014.01.012","article-title":"Predictors of biphasic reactions in the emergency department for patients with anaphylaxis","volume":"2","author":"Lee","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B13","first-page":"349","article-title":"Anaphylaxis admissions to a university hospital","volume":"89","author":"Amornmarn","year":"1992","journal-title":"J Allergy Clin Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0091-6749(95)70329-2","article-title":"Underreporting of anaphylaxis in a community emergency room","volume":"95","author":"Klein","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/pds.822","article-title":"Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study","volume":"12","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B16","first-page":"142","article-title":"Incidence of anaphylaxis and subtypes of anaphylaxis in a general hospital emergency department","volume":"21","author":"Moro Moro","year":"2011","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0091-6749(99)70392-1","article-title":"Epidemiology of anaphylaxis in Olmsted County: a population-based study","volume":"104","author":"Yocum","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jaip.2015.05.012","article-title":"Drug-induced anaphylaxis in Latin American countries","volume":"3","author":"Jares","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/ACI.0b013e32832db943","article-title":"Selective immediate hypersensitivity reactions to NSAIDs","volume":"9","author":"Canto","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1111\/all.12260","article-title":"Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs","volume":"68","author":"Kowalski","year":"2013","journal-title":"Allergy"},{"key":"B21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1081-1206(10)62221-1","article-title":"Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes","volume":"87","author":"Stevenson","year":"2001","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1365-2222.2010.03651.x","article-title":"Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: patterns of response","volume":"41","author":"Dona","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"B23","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/S0091-6749(96)70102-1","article-title":"Intolerance to nonsteroidal antiinflammatory drugs: results of controlled drug challenges in 98 patients","volume":"98","author":"Quiralte","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.iac.2015.01.008","article-title":"Anaphylaxis to drugs","volume":"35","author":"Kuruvilla","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"B25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s11882-015-0552-y","article-title":"Hypersensitivity to aspirin and other NSAIDs: diagnostic approach in patients with chronic rhinosinusitis","volume":"15","author":"Makowska","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2165\/00002018-200124110-00005","article-title":"Preventing and managing drug-induced anaphylaxis","volume":"24","author":"Drain","year":"2001","journal-title":"Drug Saf"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/archinte.1995.00430160077008","article-title":"Anaphylaxis. A review of 266 cases","volume":"155","author":"Kemp","year":"1995","journal-title":"Arch Intern Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jaci.2009.11.032","article-title":"Clavulanic acid can be the component in amoxicillin-clavulanic acid responsible for immediate hypersensitivity reactions","volume":"125","author":"Torres","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jaci.2010.03.012","article-title":"Selective allergic reactions to clavulanic acid: a report of 9 cases","volume":"126","author":"Sanchez-Morillas","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.jaci.2014.07.062","article-title":"Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis","volume":"135","author":"Macy","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1111\/all.12168","article-title":"Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the allergy vigilance network from 2002 to 2010","volume":"68","author":"Renaudin","year":"2013","journal-title":"Allergy"},{"key":"B32","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/0140-6736(90)92238-D","article-title":"Aztreonam-induced anaphylaxis","volume":"336","author":"Iglesias Cadarso","year":"1990","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/j.1365-2222.1988.tb02904.x","article-title":"Immediate hypersensitivity reactions to penicillin and related antibiotics","volume":"18","author":"Weiss","year":"1988","journal-title":"Clin Allergy"},{"key":"B34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1001\/archinte.161.1.15","article-title":"Anaphylaxis in the United States: an investigation into its epidemiology","volume":"161","author":"Neugut","year":"2001","journal-title":"Arch Intern Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/all.12214","article-title":"Diagnosis of immediate hypersensitivity reactions to radiocontrast media","volume":"68","author":"Salas","year":"2013","journal-title":"Allergy"},{"key":"B36","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1046\/j.1365-2222.1998.00258.x","article-title":"Anaphylactic reactions associated with trimethoprim","volume":"28","author":"Bijl","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.anai.2010.08.018","article-title":"Successful clarithromycin desensitization in a multiple macrolide-allergic patient","volume":"105","author":"Swamy","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/00365549209061350","article-title":"IgE-mediated reaction to vancomycin and teicoplanin after treatment with vancomycin","volume":"24","author":"Knudsen","year":"1992","journal-title":"Scand J Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e100154","DOI":"10.1371\/journal.pone.0100154","article-title":"Anaphylaxis to iodinated contrast media: clinical characteristics related with development of anaphylactic shock","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"B40","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1148\/radiology.175.3.2343107","article-title":"Adverse reactions to ionic and nonionic contrast media. A report from the Japanese committee on the safety of contrast media","volume":"175","author":"Katayama","year":"1990","journal-title":"Radiology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1148\/radiology.209.1.9769830","article-title":"Mechanisms of severe, immediate reactions to iodinated contrast material","volume":"209","author":"Laroche","year":"1998","journal-title":"Radiology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1111\/j.1398-9995.1998.tb03832.x","article-title":"Detection of IgE antibody to a radiocontrast medium","volume":"53","author":"Mita","year":"1998","journal-title":"Allergy"},{"key":"B43","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1398-9995.2008.01832.x","article-title":"Skin testing in patients with hypersensitivity reactions to iodinated contrast media \u2013 a European multicenter study","volume":"64","author":"Brockow","year":"2009","journal-title":"Allergy"},{"key":"B44","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1259\/bjr\/88469693","article-title":"Acute adverse reactions to magnetic resonance contrast media \u2013 gadolinium chelates","volume":"79","author":"Li","year":"2006","journal-title":"Br J Radiol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1148\/radiol.12112025","article-title":"Immediate hypersensitivity reaction to gadolinium-based MR contrast media","volume":"264","author":"Jung","year":"2012","journal-title":"Radiology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000366204","article-title":"Risk factors in fatal cases of anaphylaxis due to contrast media: a forensic evaluation","volume":"164","author":"Palmiere","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"B47","first-page":"363","article-title":"Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients","volume":"22","author":"Dona","year":"2012","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000450952","article-title":"Management of hypersensitivity reactions to proton pump inhibitors: a retrospective experience","volume":"171","author":"Kepil Ozdemir","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"B49","first-page":"228","article-title":"Nine cases of allergy to omeprazole","volume":"22","author":"Abdul Razzak","year":"2012","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B50","first-page":"157","article-title":"Study of cross-reactivity between proton pump inhibitors","volume":"20","author":"Sobrevia Elfau","year":"2010","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jaci.2012.04.048","article-title":"Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test","volume":"130","author":"Bonadonna","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-2222.2009.03404.x","article-title":"BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia","volume":"40","author":"Ewan","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"B53","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/aas.12858","article-title":"Anaphylaxis during general anaesthesia: experience from a drug allergy centre in the UK","volume":"61","author":"Meng","year":"2017","journal-title":"Acta Anaesthesiol Scand"},{"key":"B54","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jaci.2011.03.003","article-title":"Anaphylaxis during anesthesia in France: an 8\u2009year national survey","volume":"128","author":"Mertes","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S0750-7658(00)88460-9","article-title":"[Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994\u2013December 1996)]","volume":"18","author":"Laxenaire","year":"1999","journal-title":"Ann Fr Anesth Reanim"},{"key":"B56","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bja\/aet117","article-title":"Survival from perioperative anaphylaxis in Western Australia 2000\u20132009","volume":"111","author":"Gibbs","year":"2013","journal-title":"Br J Anaesth"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0750-7658(97)85882-0","article-title":"[Substances responsible for peranesthetic anaphylactic shock. A third French multicenter study (1992\u201394)]","volume":"15","author":"Laxenaire","year":"1996","journal-title":"Ann Fr Anesth Reanim"},{"key":"B58","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/ALN.0000000000000512","article-title":"Anaphylaxis is more common with rocuronium and succinylcholine than with atracurium","volume":"122","author":"Reddy","year":"2015","journal-title":"Anesthesiology"},{"key":"B59","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/bja\/aes506","article-title":"Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011","volume":"110","author":"Sadleir","year":"2013","journal-title":"Br J Anaesth"},{"key":"B60","first-page":"263","article-title":"Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention","volume":"11","author":"Fisher","year":"1994","journal-title":"Eur J Anaesthesiol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/00000542-200309000-00007","article-title":"Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999\u20132000","volume":"99","author":"Mertes","year":"2003","journal-title":"Anesthesiology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1034\/j.1399-6576.2001.451001.x","article-title":"Allergic reactions during anaesthesia \u2013 increased attention to the problem in Denmark and Norway","volume":"45","author":"Guttormsen","year":"2001","journal-title":"Acta Anaesthesiol Scand"},{"key":"B63","first-page":"525","article-title":"Sugammadex and hypersensitivity","volume":"42","author":"Baldo","year":"2014","journal-title":"Anaesth Intensive Care"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1111\/anae.12736","article-title":"Hypersensitivity associated with sugammadex administration: a systematic review","volume":"69","author":"Tsur","year":"2014","journal-title":"Anaesthesia"},{"key":"B65","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/1471-2253-14-92","article-title":"Three suspected cases of sugammadex-induced anaphylactic shock","volume":"14","author":"Takazawa","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"B66","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/0310057X1404200116","article-title":"Intraoperative anaphylaxis to sugammadex and a protocol for intradermal skin testing","volume":"42","author":"Sadleir","year":"2014","journal-title":"Anaesth Intensive Care"},{"key":"B67","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1093\/bja\/aev093","article-title":"Flow cytometric investigation of sugammadex-induced anaphylaxis","volume":"114","author":"Takazawa","year":"2015","journal-title":"Br J Anaesth"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/j.1365-2044.2012.07289.x","article-title":"Sugammadex and rocuronium-induced anaphylaxis","volume":"67","author":"Baldo","year":"2012","journal-title":"Anaesthesia"},{"key":"B69","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1365-2044.2011.06729.x","article-title":"Rocuronium-induced anaphylaxis is probably not mitigated by sugammadex: evidence from an in vitro experiment","volume":"66","author":"Leysen","year":"2011","journal-title":"Anaesthesia"},{"key":"B70","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2044.2011.06995.x","article-title":"The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model","volume":"67","author":"Clarke","year":"2012","journal-title":"Anaesthesia"},{"key":"B71","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/BF02802309","article-title":"Allergy to thiopentone","volume":"9","author":"Baldo","year":"1991","journal-title":"Clin Rev Allergy"},{"key":"B72","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0091-6749(05)80095-8","article-title":"Anaphylaxis during induction of general anesthesia: subsequent evaluation and management","volume":"86","author":"Moscicki","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"B73","first-page":"868","article-title":"Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005\u20132007)","volume":"78","author":"Dong","year":"2012","journal-title":"Minerva Anestesiol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/00000542-200510000-00026","article-title":"Propofol: the challenges of formulation","volume":"103","author":"Baker","year":"2005","journal-title":"Anesthesiology"},{"key":"B75","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1213\/ANE.0b013e31821b450f","article-title":"Allergic reactions to propofol in egg-allergic children","volume":"113","author":"Murphy","year":"2011","journal-title":"Anesth Analg"},{"key":"B76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/bja\/aev360","article-title":"No evidence for contraindications to the use of propofol in adults allergic to egg, soy or peanut\u2020","volume":"116","author":"Asserhoj","year":"2016","journal-title":"Br J Anaesth"},{"key":"B77","first-page":"442","article-title":"Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice","volume":"21","author":"Mertes","year":"2011","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1111\/j.1399-6576.2009.02022.x","article-title":"An anaphylactic reaction to transdermal delivered fentanyl","volume":"53","author":"Dewachter","year":"2009","journal-title":"Acta Anaesthesiol Scand"},{"key":"B79","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1034\/j.1398-9995.2000.00542.x","article-title":"Urticaria induced by meperidine allergy","volume":"55","author":"Anibarro","year":"2000","journal-title":"Allergy"},{"key":"B80","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/00000542-198910000-00003","article-title":"Anaphylaxis following administration of papaveretum. Case report: implication of IgE antibodies that react with morphine and codeine, and identification of an allergenic determinant","volume":"71","author":"Harle","year":"1989","journal-title":"Anesthesiology"},{"key":"B81","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/0310057X1204000204","article-title":"Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two","volume":"40","author":"Baldo","year":"2012","journal-title":"Anaesth Intensive Care"},{"key":"B82","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jaci.2007.04.029","article-title":"IgE-mediated allergy to chlorhexidine","volume":"120","author":"Garvey","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/cei.12424","article-title":"Multi-centre retrospective analysis of anaphylaxis during general anaesthesia in the United Kingdom: aetiology and diagnostic performance of acute serum tryptase","volume":"178","author":"Krishna","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1111\/cea.12189","article-title":"Prevalence of IgE against neuromuscular blocking agents in hairdressers and bakers","volume":"43","author":"Dong","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"B85","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/bja\/aev050","article-title":"Chlorhexidine allergy: sources of exposure in the health-care setting","volume":"114","author":"Opstrup","year":"2015","journal-title":"Br J Anaesth"},{"key":"B86","doi-asserted-by":"publisher","first-page":"98e","DOI":"10.1097\/PRS.0b013e318254b2b8","article-title":"Anaphylactic-like reaction to methylene blue: case report and review of perioperative hypersensitivity reactions","volume":"130","author":"Giladi","year":"2012","journal-title":"Plast Reconstr Surg"},{"key":"B87","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.jaci.2012.03.050","article-title":"Methylene blue-treated plasma: an increased allergy risk?","volume":"130","author":"Mertes","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jaci.2008.04.040","article-title":"Anaphylaxis to dyes during the perioperative period: reports of 14 clinical cases","volume":"122","author":"Mertes","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0750-7658(94)80038-3","article-title":"[Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study]","volume":"13","author":"Laxenaire","year":"1994","journal-title":"Ann Fr Anesth Reanim"},{"key":"B90","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.iac.2014.03.004","article-title":"Local and general anesthetics immediate hypersensitivity reactions","volume":"34","author":"Volcheck","year":"2014","journal-title":"Immunol Allergy Clin North Am"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jaci.2014.05.018","article-title":"Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals","volume":"134","author":"Clark","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1141.e","DOI":"10.1016\/j.jaci.2013.06.015","article-title":"Anaphylaxis: clinical patterns, mediator release, and severity","volume":"132","author":"Brown","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B93","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0889-8561(22)00316-2","article-title":"Difficult allergic drug reactions","volume":"11","author":"Lieberman","year":"1991","journal-title":"Immunol Allergy Clin North Am"},{"key":"B94","first-page":"159","article-title":"Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock","volume":"38","author":"Idsoe","year":"1968","journal-title":"Bull World Health Organ"},{"key":"B95","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/ACI.0b013e328355b7cb","article-title":"Drug allergy in mast cell disease","volume":"12","author":"Brockow","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/all.12193","article-title":"About the role and underlying mechanisms of cofactors in anaphylaxis","volume":"68","author":"Wolbing","year":"2013","journal-title":"Allergy"},{"key":"B97","doi-asserted-by":"publisher","first-page":"73","DOI":"10.18176\/jiaci.0046","article-title":"Mechanisms of anaphylaxis beyond IgE","volume":"26","author":"Munoz-Cano","year":"2016","journal-title":"J Investig Allergol Clin Immunol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"S80","DOI":"10.2500\/aap.2012.33.3557","article-title":"Chapter 24: anaphylaxis","volume":"33","author":"Greenberger","year":"2012","journal-title":"Allergy Asthma Proc"},{"key":"B99","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1016\/j.jaci.2009.12.981","article-title":"Anaphylaxis","volume":"125","author":"Simons","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.iac.2015.01.004","article-title":"Idiopathic anaphylaxis","volume":"35","author":"Fenny","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"B101","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.iac.2014.09.010","article-title":"Anaphylaxis and urticaria","volume":"35","author":"Williams","year":"2015","journal-title":"Immunol Allergy Clin North Am"},{"key":"B102","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s11882-016-0598-5","article-title":"Mast cells and anaphylaxis","volume":"16","author":"Lieberman","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"B103","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature14022","article-title":"Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions","volume":"519","author":"McNeil","year":"2015","journal-title":"Nature"},{"key":"B104","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jaci.2016.04.051","article-title":"Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases","volume":"138","author":"Subramanian","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"e3679","DOI":"10.1097\/MD.0000000000003679","article-title":"Hypersensitivity to fluoroquinolones: the expression of basophil activation markers depends on the clinical entity and the culprit fluoroquinolone","volume":"95","author":"Fernandez","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"B106","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jaci.2013.06.038","article-title":"Basophil activation testing","volume":"132","author":"MacGlashan","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/j.1365-2222.2010.03572.x","article-title":"Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes","volume":"40","author":"MacGlashan","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"B108","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000332150","article-title":"Marked differences in the signaling requirements for expression of CD203c and CD11b versus CD63 expression and histamine release in human basophils","volume":"159","author":"MacGlashan","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1398-9995.2009.02213.x","article-title":"Usefulness of basophil activation tests for the diagnosis of IgE-mediated allergy to quinolones","volume":"65","author":"Ben Said","year":"2010","journal-title":"Allergy"},{"key":"B110","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1398-9995.2010.02460.x","article-title":"In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones","volume":"66","author":"Aranda","year":"2011","journal-title":"Allergy"},{"key":"B111","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.mcna.2010.04.006","article-title":"The complex clinical picture of beta-lactam hypersensitivity: penicillins, cephalosporins, monobactams, carbapenems, and clavams","volume":"94","author":"Torres","year":"2010","journal-title":"Med Clin North Am"},{"key":"B112","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/j.1398-9995.2006.01120.x","article-title":"IgE antibodies to betalactams: relationship between the triggering hapten and the specificity of the immune response","volume":"61","author":"Antunez","year":"2006","journal-title":"Allergy"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jaci.2016.02.015","article-title":"Human IgE-independent systemic anaphylaxis","volume":"137","author":"Finkelman","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1056\/NEJMoa070030","article-title":"Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis","volume":"358","author":"Vadas","year":"2008","journal-title":"N Engl J Med"},{"key":"B115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.21307\/immunohematology-2019-454","article-title":"Review: IgA anaphylactic transfusion reactions. Part I. Laboratory diagnosis, incidence, and supply of IgA-deficient products","volume":"20","author":"Vassallo","year":"2004","journal-title":"Immunohematology"},{"key":"B116","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1056\/NEJM196901232800404","article-title":"Anaphylactic transfusion reactions associated with anti-IgA antibody","volume":"280","author":"Schmidt","year":"1969","journal-title":"N Engl J Med"},{"key":"B117","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.crohns.2011.08.001","article-title":"Acute and delayed hypersensitivity reactions to infliximab and adalimumab in a patient with Crohn\u2019s disease","volume":"6","author":"Steenholdt","year":"2012","journal-title":"J Crohns Colitis"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/j.1572-0241.2003.07457.x","article-title":"The incidence and management of infusion reactions to infliximab: a large center experience","volume":"98","author":"Cheifetz","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"B119","first-page":"179","article-title":"Incidence, pathomechanism and prevention of dextran-induced anaphylactoid\/anaphylactic reactions in man","volume":"48","author":"Hedin","year":"1980","journal-title":"Dev Biol Stand"},{"key":"B120","first-page":"69","article-title":"[Anaphylactic shock related to aprotinin induced by anti-aprotinin immunoglobulin G antibody alone; report of a case]","volume":"60","author":"Umeda","year":"2007","journal-title":"Kyobu Geka"},{"key":"B121","first-page":"348","article-title":"Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor","volume":"125","author":"Bergamaschini","year":"1995","journal-title":"J Lab Clin Med"},{"key":"B122","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1398-9995.1999.tb04726.x","article-title":"Anaphylactoid and anaphylactic reactions to iodinated contrast material","volume":"54","author":"Laroche","year":"1999","journal-title":"Allergy"},{"key":"B123","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1056\/NEJMoa0803200","article-title":"Contaminated heparin associated with adverse clinical events and activation of the contact system","volume":"358","author":"Kishimoto","year":"2008","journal-title":"N Engl J Med"},{"key":"B124","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0025-7125(16)30328-5","article-title":"Anaphylaxis","volume":"76","author":"Atkinson","year":"1992","journal-title":"Med Clin North Am"},{"key":"B125","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jaci.2011.01.038","article-title":"World Allergy organization anaphylaxis guidelines: summary","volume":"127","author":"Simons","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/all.12350","article-title":"International consensus on drug allergy","volume":"69","author":"Demoly","year":"2014","journal-title":"Allergy"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1111\/all.12886","article-title":"In vitro tests for drug hypersensitivity reactions. An ENDA\/EAACI drug allergy interest group position paper","volume":"71","author":"Mayorga","year":"2016","journal-title":"Allergy"},{"key":"B128","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/all.12142","article-title":"Skin test concentrations for systemically administered drugs \u2013 an ENDA\/EAACI drug allergy interest group position paper","volume":"68","author":"Brockow","year":"2013","journal-title":"Allergy"},{"key":"B129","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.anai.2010.08.002","article-title":"Drug allergy: an updated practice parameter","volume":"105","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/j.1398-9995.2008.01713.x","article-title":"Negativization rates of IgE radioimmunoassay and basophil activation test in immediate reactions to penicillins","volume":"64","author":"Fernandez","year":"2009","journal-title":"Allergy"},{"key":"B131","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1111\/j.1365-2222.2009.03237.x","article-title":"Immunoglobulin E-mediated immediate allergic reactions to dipyrone: value of basophil activation test in the identification of patients","volume":"39","author":"Gomez","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"B132","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1398-9995.2006.00978.x","article-title":"Diagnosis of neuromuscular blocking agent hypersensitivity reactions using cytofluorimetric analysis of basophils","volume":"61","author":"Kvedariene","year":"2006","journal-title":"Allergy"},{"key":"B133","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1034\/j.1398-9995.2003.00279.x","article-title":"Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations","volume":"58","author":"Aberer","year":"2003","journal-title":"Allergy"},{"key":"B134","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.jaip.2014.08.001","article-title":"Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review","volume":"2","author":"Iammatteo","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"B135","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"Schwartz","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1097\/ALN.0b013e3181d40383","article-title":"Effect of general anesthesia and orthopedic surgery on serum tryptase","volume":"112","author":"Garvey","year":"2010","journal-title":"Anesthesiology"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1111\/j.1365-2222.2011.03848.x","article-title":"An increase in serum tryptase even below 11.4 ng\/mL may indicate a mast cell-mediated hypersensitivity reaction: a prospective study in hymenoptera venom allergic patients","volume":"41","author":"Borer-Reinhold","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"B138","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1067\/mai.2000.107600","article-title":"Histamine and tryptase levels in patients with acute allergic reactions: an emergency department-based study","volume":"106","author":"Lin","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1056\/NEJM198312293092603","article-title":"Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites","volume":"309","author":"Keyzer","year":"1983","journal-title":"N Engl J Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/S0091-6749(05)80147-2","article-title":"Determination of N-methylhistamine in urine as an indicator of histamine release in immediate allergic reactions","volume":"86","author":"Stephan","year":"1990","journal-title":"J Allergy Clin Immunol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.jaci.2007.05.001","article-title":"Risk assessment in anaphylaxis: current and future approaches","volume":"120","author":"Simons","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/j.1398-9995.2007.01434.x","article-title":"Comparison of international guidelines for the emergency medical management of anaphylaxis","volume":"62","author":"Alrasbi","year":"2007","journal-title":"Allergy"},{"key":"B143","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/j.1398-9995.2007.01435.x","article-title":"H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review","volume":"62","author":"Sheikh","year":"2007","journal-title":"Allergy"},{"key":"B144","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/j.1398-9995.2010.02424.x","article-title":"Glucocorticoids for the treatment of anaphylaxis: Cochrane systematic review","volume":"65","author":"Choo","year":"2010","journal-title":"Allergy"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/all.12437","article-title":"Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology","volume":"69","author":"Muraro","year":"2014","journal-title":"Allergy"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00614\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T19:44:06Z","timestamp":1692819846000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fimmu.2017.00614\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,29]]},"references-count":145,"alternative-id":["10.3389\/fimmu.2017.00614"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2017.00614","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,29]]},"article-number":"614"}}